A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.
A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, ...
A new editorial was published in Oncoscience 's Volume 12 on January 14, 2025, titled "Pomalidomide improved immune profiles in myeloma." The editorial by researchers Hannah Seah, Vaishnavi Reddy Bade ...
Under the agreement, Neomorph will receive an undisclosed upfront payment from AbbVie and be eligible for up to $1.64 billion in aggregate option fees and milestones.